Mass Spectrometry-Based Analysis of Histone Posttranslational Modifications from Laser Microdissected Samples
Roberta Noberini1, Tiziana Bonaldi2,3
1Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy. Roberta.noberini@ieo.it.
Methods in Molecular Biology (Clifton, N.J.)
|September 4, 2023
Summary
Researchers developed a new protocol for analyzing histone posttranslational modifications (PTMs) in limited clinical samples. This method allows for sensitive detection of epigenetic changes from as few as 1000 cells.
Area of Science:
- Epigenetics and Molecular Biology
- Clinical Mass Spectrometry
- Biomarker Discovery
Background:
- Histone posttranslational modifications (PTMs) are crucial in regulating gene expression and are implicated in various diseases.
- Mass spectrometry (MS) is a powerful tool for detecting and quantifying histone PTMs.
- Current MS-based methods often require large sample amounts, limiting their use with precious clinical specimens.
Purpose of the Study:
- To develop a streamlined protocol for analyzing histone PTMs from limited clinical samples.
- To adapt existing MS techniques for low-input biological material.
- To enable the study of epigenetic modifications in microdissected tissue samples.
Main Methods:
- Streamlined protein extraction from low-amount clinical samples.
- Optimized enzymatic digestion for histone PTM analysis.
- Application of mass spectrometry for sensitive PTM detection.
- Utilized laser microdissection for sample preparation.
Main Results:
- A protocol suitable for analyzing common histone PTMs was established.
- The method is effective for samples as small as 1000 cells.
- Successful application to laser microdissected clinical tissue areas.
Conclusions:
- The developed protocol significantly expands the applicability of MS-based histone PTM analysis to limited clinical samples.
- This advancement facilitates the investigation of epigenetic mechanisms in disease pathogenesis using small tissue biopsies.
- Enables sensitive detection of epigenetic biomarkers in clinical research.


